| Sofosbuvir with NS 5A inhibitors in hepatitis C virus infection with severe renal insufficiency A Singh, S Kumari, P Kumar, A De, V Singh Journal of Viral Hepatitis 25 (12), 1501-1506, 2018 | 27 | 2018 |
| Has the time come for using MELD-Sarcopenia score? A De, A Singh, S Kumari, V Singh Journal of Hepatology 68 (6), 1324, 2018 | 7 | 2018 |
| Muscle Mass and Muscle Strength in Decompensated Cirrhosis: Correlation and Cut-Offs A De, S Kumari, A Kaur, N Kalra, A Singh, V Singh Hepatology 68, 1144A-1145A, 2018 | 1 | 2018 |
| Sofosbuvir with NS5A Inhibitors in Hepatitis C Virus (HCV) Infected Renal Transplant Recipients A Singh, S Kumari, B Leishangthem, V Singh Hepatology 68, 388A-388A, 2018 | 1 | 2018 |
| Sofosbuvir with NS5A inhibitors in hepatitis C virus infected patients with severe renal insufficiency V Singh, S Kumari, A De HEPATOLOGY 66, 635A-635A, 2017 | 1 | 2017 |
| Growth Hormone Therapy in Decompensated Cirrhosis: A Randomized Pilot Study S Kumari, B Leishangthem, A Singh, A De, N Kalra, P Dutta, V Singh HEPATOLOGY 68, 139A-139A, 2018 | | 2018 |
| Efficacy of Induced Hematopoietic Stem Cell Therapy in Decompensated Cirrhosis: An Open Label, Randomized Controlled Trial V Singh, A De, S Kumari, A Kaur, R Sharma, A Singh, A Bhalla, N Verma, ... HEPATOLOGY 68, 69A-70A, 2018 | | 2018 |
| Direct Acting Antivirals in Hepatitis C Virus Genotype 3 and Advanced Cirrhosis V Singh, S Kumari, N Verma, P Kumar, A De HEPATOLOGY 66, 829A-829A, 2017 | | 2017 |
| Sarcopenia in Decompensated Cirrhosis V Singh, A De, A Kaur, S Kumari, N Kalra, T Sehrawat HEPATOLOGY 66, 257A-257A, 2017 | | 2017 |
| Quality of Life and Outcomes after Multiple Courses of Granulocyte-Colony Stimulating Factor and Growth Hormone in Patients with Decompensated Cirrhosis V Singh, N Verma, A Kaur, R Sharma, A Bhalla, N Sharma, R Agarwal, ... HEPATOLOGY 64 (6), 1135A-1135A, 2016 | | 2016 |
